Verasitas Labs
SUBSTANCE TESTING REPORT
Comprehensive Analysis of Trenbolone Acetate Injectable Formulation
1. Introduction

This thorough examination evaluates the Trenbolone Acetate formulation to assess its chemical purity, concentration accuracy, and overall quality parameters. The analysis implements advanced analytical methodologies to verify product quality and compliance with pharmaceutical standards for injectable anabolic compounds.

2. Methodology

GC-MS and UV-Vis: Gas Chromatography-Mass Spectrometry enables precise identification and quantification of trenbolone acetate, while UV-Vis Spectrophotometry provides complementary concentration verification through specific wavelength absorption characteristics for comprehensive analytical coverage.

3. Results
Parameter Value
Sample Identification Trena A (Lot# 647281935-HIJ-2024)
Dosagen 100mg/ml
Manufacturer: Quantum
Concentration 98.3 mg/ml
Purity 98.3
Impurities < 1.7%
4. Discussion

The analytical results demonstrate that the Trenbolone Acetate formulation exhibits outstanding purity levels at 98.3%, significantly exceeding the specified range for pharmaceutical steroid preparations. Chromatographic analysis revealed an exceptionally clean profile with a dominant main peak and minimal impurity detection, indicating superior manufacturing and purification processes. Concentration determination showed excellent accuracy and consistency across multiple sample aliquots, reflecting exceptional manufacturing control and product homogeneity throughout the production batch and quality assurance.

5. Conclusion

The Trenbolone Acetate formulation substantially exceeds all quality requirements with exceptional purity levels and precise concentration values. The product demonstrates superior manufacturing quality and consistency, establishing it as a premium injectable preparation suitable for applications requiring high-purity trenbolone acetate formulations and meeting the highest pharmaceutical standards available.

Firma del doctor
Dr. María López
GC-MS Expert
03-08-2024